What You Should Know:
– Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement…
Continue Reading
Exclusive: Pangaea Data, AstraZeneca leverage AI to detect rare diseases | MobiHealthNews
Skip to main content…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ronen Veksler, Co-Founder and CEO at Promise Bio. Promise Bio is an…
Continue Reading
Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for…
Continue Reading
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an…
Continue Reading
A regular panel discussion including the brightest minds in the healthcare industry. With a focus on digital health, DHR holds collaborative conversations with physicians, patients, scientists, creatives, technologists, and executives devoting their efforts to…
Continue Reading
San Francisco-based data intelligence and AI provider Databricks has raised $10 billion of expected non-dilutive financing in a Series J funding round, completing $8.6 billion to date. The new funding brings the company’s valuation…
Continue Reading
Precision medicine startup Promise Bio announced that it has emerged from stealth with an $8.3 million seed investment.Awz Ventures led the round with funding from AION Lab’s venture seeding track from AstraZeneca and Pfizer,…
Continue Reading
Sheffield-based insomnia medtech firm SleepCogni has raised £300,000, bringing its total funding to £3.9m.
The funding was raised in an Enterprise Investment Scheme pre-approved bridging round, supported by existing investors and grants.
Richard Mills, chief executive…
Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
